 Becton Dickinson and Co said on Wednesday the U.S. government will invest 42 million to expand the medical technology companys manufacturing lines for injection devices to support vaccination efforts against COVID-19. The investment is under a public-private partnership with the Biomedical Advanced Research and Development Authority BARDA, part of the U.S. Health and Human Services Office, Becton Dickinson said. BARDA has invested more than 3 billion in vaccines and funded more than 30 projects as part of Operation Warp Speed, the White House program aimed at accelerating access to vaccines and treatments for the new coronavirus. 